cyclooctanes - CISMeF

Preferred Label : cyclooctanes;

MeSH definition : A group of compounds with an 8-carbon ring. They may be saturated or unsaturated.;

MeSH hyponym : cyclooctodienes; benzocyclooctenes; cyclooctenes;

Related MeSH term : benzocyclooctanes; dibenzocyclooctanes;

Is substance : O;

Détails

Origin ID

D034242;

UMLS CUI

C1136007;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- benzocyclooctanes [MeSH concept]
- benzocyclooctenes [MeSH concept]
- cyclooctanes [MeSH concept]
- cyclooctenes [MeSH concept]
- cyclooctodienes [MeSH concept]
- dibenzocyclooctanes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (18F)azadibenzocyclooctyne [MeSH Supplementary Concept]
- (2.2.1) hept-2'-en-2'-amino-N-azatricyclo (3.2.1.0(2,4)) octane [MeSH Supplementary Concept]
- 1,2,5,6-tetrabromocyclooctane [MeSH Supplementary Concept]
- 1,2-diphosphacyclooctatetraene [MeSH Supplementary Concept]
- 1,3,5,7-cyclooctatetraene [MeSH Supplementary Concept]
- 1,3,5,7-tetrakis(methylidene)cyclooctane [MeSH Supplementary Concept]
- 1,3-cyclooctadiene [MeSH Supplementary Concept]
- 1,5-diaza-3,7-diphosphacyclooctane [MeSH Supplementary Concept]
- 1,5-naphthyridinone oxabicyclooctane [MeSH Supplementary Concept]
- 1-(1-cyclooctylmethyl-5-(1-hydroxy-1-methylethyl)-1,2,3,6-tetrahydropyridin-4-yl)-3-ethyl-1,3-dihydrobenzoimidazol-2-one [MeSH Supplementary Concept]
- 2',3',4',5,5',6,7,8,9,10-decahydro-2-(5-(4-fluorophenyl)-1-methylpyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)spiro(6,9-methanobenzocycloocten-11,3'-(1,2,5)thiadiazole) 1',1'-dioxide [MeSH Supplementary Concept]
- 2-(3,4-methylenedioxyphenyl)-6-(3,4-dihydroxyphenyl)-3,7-dioxabicyclo(3.3.0)octane [MeSH Supplementary Concept]
- 2-methyl-7-methylene-1,5-dithiacyclooctane [MeSH Supplementary Concept]
- 4-cycloocten-1-carbaldehyde [MeSH Supplementary Concept]
- 5,6,7,8,10-hexahydro-5.9-methanobicyclobenzocyclooctene [MeSH Supplementary Concept]
- 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-5-(2-methylbut-2-enoyl)oxy(1,3)benzodioxolo(5',6'-3,4)cycloocta(1,2-f)(1,3)benzodioxol-6,8-diol [MeSH Supplementary Concept]
- 7-methyl-1,3,5-cyclooctatriene [MeSH Supplementary Concept]
- 8-acetoxy-5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-5-(2-methylbut-2-enoyl)oxy(1,3)benzodioxolo(5',6'-3,4)cycloocta(1,2-f)(1,3)benzodioxol-6-ol [MeSH Supplementary Concept]
- 8-azabicyclo(3.2.1)octane [MeSH Supplementary Concept]
- N-(9-((5-chloro-2-methoxyphenyl)amino)-4,5,6,7-tetrahydrocycloocta(1,2-d-3,4-d')bis(thiazole)-2-yl)isobutyramide [MeSH Supplementary Concept]
- PC 314 [MeSH Supplementary Concept]
- WCK 4234 [MeSH Supplementary Concept]
- carapin [MeSH Supplementary Concept]
- carboxymethylmonobenzocyclooctyne [MeSH Supplementary Concept]
- cefepime-zidebactam [MeSH Supplementary Concept]
- ceramidastin [MeSH Supplementary Concept]
- cyclooctane [MeSH Supplementary Concept]
- cyclooctanol [MeSH Supplementary Concept]
- cyclooctanone [MeSH Supplementary Concept]
- cyclooctylamine [MeSH Supplementary Concept]
- cyclooctylpyranone [MeSH Supplementary Concept]
- cycluron [MeSH Supplementary Concept]
- diazabicyclo(2.2.2)octane [MeSH Supplementary Concept]
- dibarrelane [MeSH Supplementary Concept]
- dibenzo(a,c)cyclooctadiene [MeSH Supplementary Concept]
- dibenzocyclooctadiene [MeSH Supplementary Concept]
- dibenzocyclooctadiene lignan [MeSH Supplementary Concept]
- dicyclopenta(a,d)cyclooctane [MeSH Supplementary Concept]
- fusicoccin R [MeSH Supplementary Concept]
- fusicoccin S [MeSH Supplementary Concept]
- heteroclitin H [MeSH Supplementary Concept]
- heteroclitin I [MeSH Supplementary Concept]
- heteroclitin J [MeSH Supplementary Concept]
- interiotherin A [MeSH Supplementary Concept]
- interiotherin B [MeSH Supplementary Concept]
- interiotherin C [MeSH Supplementary Concept]
- interiotherin D [MeSH Supplementary Concept]
- isoschizandrin [MeSH Supplementary Concept]
- kadsulignan L [MeSH Supplementary Concept]
- kadsuralignan F [MeSH Supplementary Concept]
- kadsuralignan G [MeSH Supplementary Concept]
- kadsuralignan L [MeSH Supplementary Concept]
- kadsurenin C [MeSH Supplementary Concept]
- kadsurenin K [MeSH Supplementary Concept]
- kadsurenin L [MeSH Supplementary Concept]
- kadsurin [MeSH Supplementary Concept]
- kadsutherin D [MeSH Supplementary Concept]
- neglschisandrin C [MeSH Supplementary Concept]
- neglschisandrin D [MeSH Supplementary Concept]
- ni(cod)(bpy) [MeSH Supplementary Concept]
- peniciherquamide A [MeSH Supplementary Concept]
- phomopsiol [MeSH Supplementary Concept]
- rubisandrin C [MeSH Supplementary Concept]
- schisandrol A [MeSH Supplementary Concept]
- schisanhenol [MeSH Supplementary Concept]
- schisanhenol B [MeSH Supplementary Concept]
- schisantherin B [MeSH Supplementary Concept]
- schisphenin A [MeSH Supplementary Concept]
- schizandrer A [MeSH Supplementary Concept]
- schizandrin [MeSH Supplementary Concept]
- schizandrin A [MeSH Supplementary Concept]
- schizandrin B [MeSH Supplementary Concept]
- schizandrin C [MeSH Supplementary Concept]
- schizandrol B [MeSH Supplementary Concept]
- serpendione [MeSH Supplementary Concept]
- vinylcyclooctane [MeSH Supplementary Concept]
- zidebactam [MeSH Supplementary Concept]
- zopfiellin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients